Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.

Dosing interval of natalizumab in MS: Do good things come to those who wait?

Clifford DB, Tyler KL. Dosing interval of natalizumab in MS: Do good things come to those who wait? Neurology. 2019 10 08; 93(15):655-656.

View in: PubMed

collapse authors with profiles


Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)